Clinical Trials
387 trialsNeoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Comparing Whole Brain Radiotherapy Using a Technique That Avoids the Hippocampus to Stereotactic Radiosurgery in Patients With Cancer That Has Spread to the Brain and Come Back in Other Areas of the Brain After Earlier Stereotactic Radiosurgery
NRG Oncology
Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer
NRG Oncology
Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC
University of Texas Southwestern Medical Center
Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients
Columbia University
Exercise as Maintenance Therapy in Advanced Lung Cancer
Indiana University
Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)
McGill University Health Centre/Research Institute of the McGill University Health Centre
PIPSeN
Gustave Roussy, Cancer Campus, Grand Paris
Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer
Roswell Park Cancer Institute
Phase I Trial of Atezolizumab and Interleukin-12 Gene Therapy in Metastatic Non-Small Cell Lung Cancer With Progression on First-Line Immunotherapy With or Without Chemotherapy
The Methodist Hospital Research Institute
Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases
M.D. Anderson Cancer Center
CONCORDE
Centre Oscar Lambret
Ascorbate With Durvalumab in Non-Small Cell Lung Cancer (NSCLC)
University of Iowa
OPTIMUNELUNG
Institut Bergonié
Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
M.D. Anderson Cancer Center
Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer
Thomas Jefferson University
Rucaparib and Pembrolizumab for Maintenance Therapy in Stage IV Non-Squamous Non-Small Cell Lung Cancer
University of Michigan Rogel Cancer Center
Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen
Mayo Clinic
Atezolizumab and Varlilumab in Combination With Radiation Therapy for NSCLC
Rutgers, The State University of New Jersey
Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease
Roswell Park Cancer Institute
PRIMING
Royal Marsden NHS Foundation Trust
EPITOP-01
Institut Paoli-Calmettes
Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
University of Pittsburgh
Biomarkers of Response to Ipilimumab and Nivolumab in First-line NSCLC
Dana-Farber Cancer Institute
ATLAS
University Health Network, Toronto
BRIDGE
Mario Negri Institute for Pharmacological Research
Tarlox and Sotorasib in Patients With KRAS G12C Mutations
Medical University of South Carolina
Treatment of Multifocal Lung Adenocarcinoma
Mayo Clinic
Atezolizumab Plus 8 Gy Single-fraction Radiotherapy for Advanced Oligoprogressive NSCLC
Oncology Institute of Southern Switzerland
SABRseq
Peter MacCallum Cancer Centre, Australia
IRRADIATE-Lung
NYU Langone Health
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer
Alliance for Clinical Trials in Oncology
AM-003
University of Virginia
The Safety and Feasibility of Costal Bone Marrow Aspiration During Thoracic Surgery
Universitair Ziekenhuis Brussel
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
ESR1814205
Rush University Medical Center
Bronchial Mapping (GCC 1635)
University of Maryland, Baltimore
Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer
Massachusetts General Hospital
Induction Chemo-Nivo in Unresectable Stage III NSCLC
University of Kentucky
TESTING
Abramson Cancer Center at Penn Medicine
Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
Yale University
Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients
Fundación GECP
Abequolixron (RGX-104) and Durvalumab in Lung Cancer
UNC Lineberger Comprehensive Cancer Center
Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial
Peter MacCallum Cancer Centre, Australia
Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.
Spanish Lung Cancer Group
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS
Spanish Lung Cancer Group
Pre-Incisional Ketorolac for Patients Undergoing Surgery for Non-Small Cell Lung Cancer and Renal Cell Carcinoma
Emory University
Liquid Biopsy to Reduce Time to Treatment for Advanced Nonsquamous NSCLC Diagnosed at Outside Sites
Case Comprehensive Cancer Center
Pulmonary Rehabilitation Before Lung Cancer Resection
Alliance for Clinical Trials in Oncology